Switch theme
Sign up to access all valuation multiples
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe.
1983
76
LTM Revenue $134M
LTM EBITDA $103M
$18.8B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Pro Medicus has a last 12-month revenue (LTM) of $134M and a last 12-month EBITDA of $103M.
In the most recent fiscal year, Pro Medicus achieved revenue of $104M and an EBITDA of $77.5M.
Pro Medicus expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Pro Medicus valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $134M | XXX | $104M | XXX | XXX | XXX |
| Gross Profit | $134M | XXX | $104M | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | 100% | XXX | XXX | XXX |
| EBITDA | $103M | XXX | $77.5M | XXX | XXX | XXX |
| EBITDA Margin | 77% | XXX | 75% | XXX | XXX | XXX |
| EBIT | $98.0M | XXX | $72.1M | XXX | XXX | XXX |
| EBIT Margin | 73% | XXX | 69% | XXX | XXX | XXX |
| Net Profit | $71.5M | XXX | $53.2M | XXX | XXX | XXX |
| Net Margin | 53% | XXX | 51% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Pro Medicus's stock price is AUD 282 (or $181).
Pro Medicus has current market cap of AUD 29.5B (or $18.9B), and EV of AUD 29.3B (or $18.8B).
See Pro Medicus trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $18.8B | $18.9B | XXX | XXX | XXX | XXX | $0.69 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Pro Medicus has market cap of $18.9B and EV of $18.8B.
Pro Medicus's trades at 156.3x EV/Revenue multiple, and 205.8x EV/EBITDA.
Equity research analysts estimate Pro Medicus's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Pro Medicus has a P/E ratio of 264.5x.
See valuation multiples for Pro Medicus and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $18.9B | XXX | $18.9B | XXX | XXX | XXX |
| EV (current) | $18.8B | XXX | $18.8B | XXX | XXX | XXX |
| EV/Revenue | 140.2x | XXX | 156.3x | XXX | XXX | XXX |
| EV/EBITDA | 182.6x | XXX | 205.8x | XXX | XXX | XXX |
| EV/EBIT | 191.9x | XXX | 218.2x | XXX | XXX | XXX |
| EV/Gross Profit | 140.6x | XXX | n/a | XXX | XXX | XXX |
| P/E | 264.5x | XXX | 299.5x | XXX | XXX | XXX |
| EV/FCF | 267.7x | XXX | 313.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialPro Medicus's last 12 month revenue growth is 34%
Pro Medicus's revenue per employee in the last FY averaged $1.4M, while opex per employee averaged $0.4M for the same period.
Pro Medicus's rule of 40 is 108% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Pro Medicus's rule of X is 162% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Pro Medicus and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 34% | XXX | 33% | XXX | XXX | XXX |
| EBITDA Margin | 77% | XXX | 76% | XXX | XXX | XXX |
| EBITDA Growth | 39% | XXX | 36% | XXX | XXX | XXX |
| Rule of 40 | 108% | XXX | 110% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 162% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $1.4M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 2% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 30% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Alcidion Group | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Doctor Care Anywhere | XXX | XXX | XXX | XXX | XXX | XXX |
| Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Pro Medicus acquired XXX companies to date.
Last acquisition by Pro Medicus was XXXXXXXX, XXXXX XXXXX XXXXXX . Pro Medicus acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Pro Medicus founded? | Pro Medicus was founded in 1983. |
| Where is Pro Medicus headquartered? | Pro Medicus is headquartered in Australia. |
| How many employees does Pro Medicus have? | As of today, Pro Medicus has 76 employees. |
| Who is the CEO of Pro Medicus? | Pro Medicus's CEO is Dr. Sam Aaron Hupert, M.B.B.S.. |
| Is Pro Medicus publicy listed? | Yes, Pro Medicus is a public company listed on ASX. |
| What is the stock symbol of Pro Medicus? | Pro Medicus trades under PME ticker. |
| When did Pro Medicus go public? | Pro Medicus went public in 2000. |
| Who are competitors of Pro Medicus? | Similar companies to Pro Medicus include e.g. Benevolent AI, Alcidion Group, CurveBeam AI, Doctor Care Anywhere. |
| What is the current market cap of Pro Medicus? | Pro Medicus's current market cap is $18.9B |
| What is the current revenue of Pro Medicus? | Pro Medicus's last 12 months revenue is $134M. |
| What is the current revenue growth of Pro Medicus? | Pro Medicus revenue growth (NTM/LTM) is 34%. |
| What is the current EV/Revenue multiple of Pro Medicus? | Current revenue multiple of Pro Medicus is 140.2x. |
| Is Pro Medicus profitable? | Yes, Pro Medicus is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Pro Medicus? | Pro Medicus's last 12 months EBITDA is $103M. |
| What is Pro Medicus's EBITDA margin? | Pro Medicus's last 12 months EBITDA margin is 77%. |
| What is the current EV/EBITDA multiple of Pro Medicus? | Current EBITDA multiple of Pro Medicus is 182.6x. |
| What is the current FCF of Pro Medicus? | Pro Medicus's last 12 months FCF is $70.3M. |
| What is Pro Medicus's FCF margin? | Pro Medicus's last 12 months FCF margin is 52%. |
| What is the current EV/FCF multiple of Pro Medicus? | Current FCF multiple of Pro Medicus is 267.7x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
